↑ Rising
Business
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
6sources
8articles
5velocity
+75%since first seen
1h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (8)
- Novo Nordisk (CPSE:NOVO B) Raised Its Outlook, Is The Stock Still Undervalued? Yahoo Finance · 8h ago
- No pain, no gain at Novo The Economist · 8h ago
- Novo Nordisk CEO: Wegovy pill 'exceeded our expectations' Yahoo Finance · 8h ago
- Novo Boosts Forecast on Demand for Wegovy Pill, Ozempic Bloomberg.com · 8h ago
- Novo Nordisk Weight-Loss Pill Sales Soar. One Other Earnings Revelation Boosting the Stock. Barron's · 8h ago
- Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22% Yahoo Finance · 8h ago
- Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook CNBC · 8h ago
- Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues WSJ · 8h ago
Related trends
▲ Peaking
Business
Apple still charging 300% of costs on iPhone storage upgrades, says WSJ
▲ Peaking
Business
US voters roundly reject data centers in ballot measures
▲ Peaking
Business
McDonald's says US sales on the mend as promotions draw diners back
▲ Peaking
Business
Stock Market Today: Stock Futures Drop as Investors Weigh Democratic Gains
▲ Peaking
Business
U.S. Loses $35.1 Billion From Its Bet On Intel's Imploding Stock
▲ Peaking
Business